From: Multi-center prospective study on central line-associated bloodstream infections in 79 ICUs of China
Region of China | No. of hospitalization days | No. of device days | No. of patients with CLABSI | Utilization rate of CVCs,% M (Q1, Q2, Q3) | CLABSI rate, per 1000 catheter-days M (Q1, Q2, Q3) | P value |
---|---|---|---|---|---|---|
Central China | 230,783 | 87,818 | 120 | 38.05 (29.94, 38.29, 54.83) | 1.37 (.00, .52, 1.60) | Ā |
Eastern China | 667,988 | 285,205 | 462 | 42.7 (28.47, 45.25, 60.24) | 1.62 (.00, 1.00, 2.57) | .0964 |
Northeast China | 64,038 | 28,522 | 22 | 44.54 (36.83, 37.15, 45.09) | .77 (.00, .62, .91) | .0095 |
Western China | 126,113 | 65,040 | 98 | 51.57 (37.13, 63.82, 84.78) | 1.51 (.00, .91, 1.73) | .4728 |